miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9

Oncology Letters
Lin WuKang Li

Abstract

Cisplatin is effective as a single agent or in combination with other drugs for the treatment of non-small cell lung cancer (NSCLC). A concerning clinical challenge with cisplatin-based NSCLC chemotherapy is the intrinsic and acquired chemoresistance to cisplatin. The sterile α motif domain-containing (SAMD9) gene has been reported as a potent tumor suppressor gene that inhibits tumorigenesis and progression of NSCLC. microRNAs (miRNA) have been revealed to play important roles in the regulation of cancer chemoresistance. To the best of our knowledge the present study explored the role of miRNA/SAMD9 signaling in regulating cisplatin chemoresistance in NSCLC for the first time. Out of the several candidate miRNAs predicted to bind the 3'-untranslated region (UTR) of the SAMD9 gene, miRNA-96 (miR-96) demonstrated significant target-sequence-specific inhibition of the SAMD9 3'-UTR luciferase reporter activity in NSCLC cells. In addition, while NSCLC tumor samples exhibited significantly higher expression levels of miR-96 compared with adjacent normal tissues, the expression levels of SAMD9 were significantly lower than those in adjacent normal tissues. miR-96 and SAMD9 were overexpressed and knocked down in the human NSCLC H358 a...Continue Reading

References

Apr 26, 1969·Nature·B RosenbergV H Mansour
Jun 1, 2005·Current Opinion in Structural Biology·Witold FilipowiczRamesh S Pillai
Apr 11, 2009·Biochemical and Biophysical Research Communications·Hiroya AsouToshiya Inaba
Feb 9, 2010·Cell Adhesion & Migration·Arnaud Van Den BroeckSylvie Gazzeri
Oct 19, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Alex Chang
Mar 23, 2011·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Johannes MerkIduna Fichtner
Sep 13, 2011·Nature Structural & Molecular Biology·David M GarciaDavid P Bartel
Jul 17, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bing FengLong-Bang Chen
Oct 24, 2013·Biochemical and Biophysical Research Communications·Mo LiuAnxun Wang
Oct 8, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Juan LiGuojun Zhang
Dec 3, 2014·Biochemical and Biophysical Research Communications·Qing MaDian-Sheng Zhong
Dec 4, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haifeng XiaHaitao Ma

❮ Previous
Next ❯

Citations

Nov 22, 2016·Expert Opinion on Drug Discovery·Jing XueXiaoming Liu
Mar 10, 2017·Genes·Duncan Ayers, Jo Vandesompele
Sep 12, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Zhengwei Li, Ying Wang
Mar 28, 2017·The Journal of Clinical Investigation·Federica BuonocoreJohn C Achermann
Feb 1, 2018·Oncotarget·Irina FadejevaAndelko Hrzenjak
Aug 2, 2018·International Journal of Oncology·Pin GuoLijuan Zhang
Aug 16, 2019·International Journal of Molecular Sciences·Giuseppe MurdacaSebastiano Gangemi
Jan 18, 2019·Experimental and Therapeutic Medicine·Li ChaoLiu Yi
Nov 22, 2019·Cancer Cell International·Xupeng ZhaoYong Zhou
Jan 11, 2021·Experimental and Molecular Pathology·Mohammad TaheriMarcel E Dinger
Feb 5, 2021·Journal of Cellular and Molecular Medicine·Liting DingHongbo Xin
Sep 20, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Metin ÇalışkanVildan Bozok Çetintaş
Dec 4, 2020·Pharmaceuticals·Ilaria GuerrieroArturo Orlacchio
Sep 28, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Meenu MehtaKamal Dua

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
transfection
PCR

Software Mentioned

SPSS
TargetScan

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.